IART Q2 2023 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena

IARTIntegra LifeSciences Holdings Corporation

$738M

Q2 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$381M-4.2% YoY

Gross Profit

$207M54.3% margin

Operating Income

$13M3.3% margin

Net Income

$4M1.1% margin

EPS (Diluted)

$0.05

QoQ Revenue Growth

+0.1%

Cash Flow

Operating Cash Flow

$28M

Free Cash Flow

$13M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$3.8B

Total Liabilities

$2.1B

Stockholders' Equity

$1.7B

Cash & Equivalents

$309M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$381M	$398M	-4.2%
Gross Profit	$207M	$249M	-17.0%
Operating Income	$13M	$60M	-79.1%
Net Income	$4M	$45M	-90.7%

Revenue Segments

Codman Specialty Surgical

$271M71%

Tissue Technologies

$110M29%

Geographic Segments

UNITED STATES

$277M73%

Asia Pacific

$48M13%

Europe

$37M10%

Rest Of World

$19M5%